Status:
COMPLETED
COVID-19 Vaccination Hesitancy in Adults With Sickle Cell Disease
Lead Sponsor:
Duke University
Collaborating Sponsors:
American Society of Hematology
Conditions:
Sickle Cell Disease
COVID-19 Vaccine
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to test an COVID-19 vaccination information video in adults with sickle cell disease. The main questions it aims to answer are why are some adults with sickle cell d...
Detailed Description
In this research study, we seek to gain a better understanding of reasons for COVID-19 vaccine hesitancy in adults with sickle cell disease (SCD). We will develop a SCD-specific COVID-19 vaccination i...
Eligibility Criteria
Inclusion
- diagnosis of sickle cell disease
Exclusion
- unable to read or understand spoken English to complete the survey
Key Trial Info
Start Date :
September 19 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2024
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT05998824
Start Date
September 19 2023
End Date
September 30 2024
Last Update
December 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke Adult Sickle Cell Program
Durham, North Carolina, United States, 27710